CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,540 | -58.2% | 7,626 | -33.7% | 0.00% | – |
Q2 2023 | $41,964 | -77.3% | 11,497 | -69.7% | 0.00% | – |
Q1 2022 | $185,000 | -59.7% | 37,943 | -6.5% | 0.00% | -100.0% |
Q4 2021 | $459,000 | -19.8% | 40,572 | +3.4% | 0.00% | 0.0% |
Q3 2021 | $572,000 | +19.7% | 39,229 | -4.5% | 0.00% | 0.0% |
Q2 2021 | $478,000 | -11.6% | 41,060 | -7.3% | 0.00% | 0.0% |
Q1 2021 | $541,000 | -2.3% | 44,311 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $554,000 | -15.4% | 44,311 | +1.8% | 0.00% | 0.0% |
Q3 2020 | $655,000 | -36.1% | 43,545 | +4.2% | 0.00% | -50.0% |
Q2 2020 | $1,025,000 | +133.5% | 41,809 | +35.3% | 0.00% | +100.0% |
Q1 2020 | $439,000 | -9.5% | 30,904 | +1.2% | 0.00% | 0.0% |
Q4 2019 | $485,000 | +88.0% | 30,549 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $258,000 | +2.0% | 30,549 | +8.4% | 0.00% | – |
Q2 2019 | $253,000 | +16.1% | 28,175 | 0.0% | 0.00% | – |
Q1 2019 | $218,000 | +71.7% | 28,175 | +4.1% | 0.00% | – |
Q4 2018 | $127,000 | -48.2% | 27,053 | 0.0% | 0.00% | – |
Q3 2018 | $245,000 | -23.7% | 27,053 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $321,000 | +68.1% | 27,053 | +99.3% | 0.00% | – |
Q1 2018 | $191,000 | – | 13,573 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |